We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+37.51%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
–
AUM
$187M
AUM Growth
+$108M
Cap. Flow
+$94.7M
Cap. Flow %
50.59%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$85.9M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$8.61M
3
RXDX
Ignyta, Inc.
RXDX
+$170K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$1.7B
$102M 54.68%
+3,688,448
New +$85.9M
COLL icon
2
Collegium Pharmaceutical
COLL
$820M
$19M 10.14%
1,887,332
– –
FOLD
3
DELISTED
Amicus Therapeutics
FOLD
$18.5M 9.9%
2,600,014
– –
IOVA icon
4
Iovance Biotherapeutics
IOVA
$3.74B
$16.3M 8.71%
2,188,331
– –
SRRA
5
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$12.4M 6.63%
202,803
+148,148
+271% +$8.61M
CDTX
6
DELISTED
Cidara Therapeutics
CDTX
$10.2M 5.47%
65,613
– –
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
$8.37M 4.47%
973,693
+23,327
+2% +$170K

Similar funds

ACMV
August Capital Management VI Palo Alto, California $1.39M AUM
FRCMI
First Round Capital Management III Philadelphia, Pennsylvania $418K AUM
DB
DCVC Bio Palo Alto, California $313K AUM
NAM
Newfleet Asset Management Hartford, Connecticut $2.05M AUM 27.28% 1-Year Est. Return
AP
Atlas Principals Charlotte, North Carolina $2.19M AUM 56.71% 1-Year Est. Return
ID
Inspire Developers Forest Hills, New York $4.07M AUM
CI
CMT Investments Chicago, Illinois $5M AUM 15.27% 1-Year Est. Return
DIF
Discovery Investment Fund Singapore $6.98M AUM

Frazier Management's Q1 2017 Portfolio in Review

As of Q1 2017, Frazier Management held 7 positions worth $187M, up 136% from $79.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Frazier Management deployed $94.7M of net new capital in Q1 2017, opening 1 new position and adding to 2 existing holdings. Its largest new stake was AnaptysBio: 3,688,448 shares worth $102M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Frazier Management's largest Q1 2017 buy was AnaptysBio: 3,688,448 shares worth $102M.
  • Frazier Management added most to Sierra Oncology, Inc. Common Stock in Q1 2017, an estimated $8.61M increase.
  • Frazier Management's ten largest holdings make up 100% of its $187M portfolio in Q1 2017.
  • Frazier Management opened 1 new position and closed 0 in Q1 2017.
  • Frazier Management's portfolio value rose 136% quarter-over-quarter to $187M.

Based on Frazier Management's 13F filing for Q1 2017, filed 12 May 2017.